Jobs / United States / Sanofi US Services INC
Associate Director, Forecasting - Dermatology
Sanofi US Services INC · 🇺🇸 Cambridge, MA
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Sanofi US Services INC paid sponsored hires in similar roles2 certified filings for “Associate Director” (Regulatory Affairs Managers) in MA: $147k–$147k, median $147k. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Sanofi US Services INC
The US Department of Labor certified 47 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 29 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Sanofi US Services INC →
About the role
Job title: Associate Director, Forecasting - Dermatology • Location: Cambridge, MA About the Job: As Associate Director, Forecasting – Dermatology within our I&A team, you will be responsible for leading commercial forecasting activities for Dupixent's US Dermatology portfolio as part of the Sanofi US Specialty Care Business Operations organization. In this role, you will be an integral partner to the US Dupixent Commercial team, developing short and long-range sales forecasts for in-line and future Dermatology indications while providing strategic insights on potential threats and opportunities. This position is based in Cambridge, MA and will report to the Director, Forecasting – US Dupixent. Ready to push the limits of what’s possible? Join Sanofi in one of our corporate functions and you can play a vital part in the performance of our entire business while helping to make an impact on millions around the world About Sanofi: We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system – and innovative pipeline – enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives. Main Responsibilities: • Collaborate with US Dupixent Dermatology team and cross-functional partners to develop, document, and communicate accurate long-term patient/volume / revenue forecasts for annual Strategic Planning & Budget cycles. • Collaborate with US Dupixent Finance & other US Specialty Care forecasters in forecast cycle planning to promote harmonization across therapeutic areas. • Support model enhancements to ensure forecasts for in-line & launch products reflect strategic direction of each brand (e.g., segmentation, patient flow, etc.). • Collaborate with Market Research to plan & design studies that provide key forecast inputs (e.g., demand study / conjoint exercises). • Partner with Market Access to incorporate the latest access assumptions, conduct payer mix analyses, and calculate government program obligatory rebates. • When necessary, use resources such as analogue analyses & external forecasts (e.g., syndicated / analyst reports) to pressure-test assumptions. • Develop forecast scenarios to quantify potential risks & opportunities. • Contribute to US Dupixent leadership reviews by explaining key Dermatology forecast assumptions & outputs, from epidemiology through ex-factory volumes. • Partner with US SPC Finance team to develop & deliver forecast review presentations for US Dupixent Commercial, SPC NA, & SPC Global leadership. • Work with Global Dupixent forecasting to ensure that US deliverables align with Global guidance and properly integrate with the Global forecast aggregation process. • Provide monthly updates to US Dupixent leadership on performance and near-term forecast outlook, integrating latest actuals, analytics, Market Research, CI, etc. • In partnership with Analytics & Finance colleagues, provide key end-of-month closing deliverables (i.e., price / volume & demand / inventory analyses). • Collaborate with Commercial & Finance leadership to revise near-term forecast, accounting for latest actuals & emerging market opportunities/threats. • Conduct ad-hoc meetings with US Dupixent Dermatology brand leads to review key updates, monitor areas of focus, and proactively provide data-driven insights. • Work with Finance and Demand Planning to ensure the most appropriate forecast (by SKU) is delivered for monthly supply chain planning activities. • When necessary, attend S&OP meetings to speak to forecast variances or events (e.g., launches, new indications, new devices).